Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?
{{output}}
Proteomics-based identification of biomarkers for fetal abnormalities and pregnancy complications in amniotic fluid (AF) has made significant progress in the past 5 years. This is attributed mainly to advances in mass spectrometry-based proteomic technologies ... ...
